Subtle losses of memory or changes in behaviour are the rst outward signs of Alzheimer's disease. Slowly but relentlessly, cognition declines, language is disrupted and behavioural changes accumulate, diminishing a person's independence. These changes are underpinned by both structural and microscopic changes in the brain.
0-5%
of people with mild cognitive impairment* go on to develop dementia each year. *Mild cognitive impairment is an abnormal decline in cognition that, unlike Alzheimer's disease, does not a ect daily living. It is considered to be a precursor to the condition.
Amyloid-β plaques 
ST UCTU AL CHANGES
Alzheimer's disease spreads through the brain, causing a progressive loss of the connections between neurons (synapses), and then neurons themselves. In the later stages of the condition, the brain is noticeably shrunken -the cerebral cortex appears shrivelled and the uid-lled ventricles are expanded.
8-0 YEARS
The average time for which a person with Alzheimer's disease lives after diagnosis.
MIC OSCOPIC CHANGES
Two hallmarks of Alzheimer's disease are visible only under the microscope.
Accumulations of the peptide amyloid-β, known as plaques, form between neurons. Microtubuleassociated protein tau aggregates into neuro brillary tangles inside neurons, and these structures persist after neurons have died.
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The hippocampus, an area of the brain that is crucial for memory formation, is one of the rst areas to be a ected. Tissue loss is severe.
ALZHEIMER'S DISEASE
Amyloid-β plaque Neuro brillary tangle
Nucleus GENETICS Around 1% of cases of Alzheimer's disease are caused by mutations in the genes APP, PSEN1 or PSEN2, which a ect amyloid-β processing. Certain mutations in APOE and TREM2
can increase the risk of developing the more common sporadic form of the condition.
SEX
The overall incidence of Alzheimer's disease in women is up to twice that of men 4 . This di erence cannot be explained by women's greater life expectancy -but hormones and lifestyle might play a part.
LIFESTYLE
A raft of potentially modi able risk factors for Alzheimer's disease have been identi ed. These include diabetes, obesity, depression, smoking and low educational attainment.
AGEING AND G OWING
In 2015, almost 50 million people worldwide had dementia 2 . As the population grows and ages, the number a ected is expected to surpass 130 million people by 2050.
LOCAL LESSONS
The prevalence of Alzheimer's disease (left) in people aged 60 or above is highest in north Africa and the Middle East, and the condition is least common in central Europe 2 . In a uent countries in the West, such as the United Kingdom, a decline in the prevalence of Alzheimer's disease in the elderly has been observed (right) 3 . This suggests that concurrent changes in lifestyle might have provided some protection from dementia (see page S18).
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A GLOBAL P OBLEM 
ISK FACTO S
T EATMENTS TH OUGH UNDE STANDING
The amyloid hypothesis is the most widely accepted mechanism to account for Alzheimer's disease. It posits that the condition is driven by aggregation of amyloid-β. The proposed sequence of events presents several opportunities for intervention, but so far no drug has been shown to reverse, stop or even slow the condition's advance.
Amyloid-β is produced by the cleavage of amyloid precursor protein in the membrane of neurons.
In the space between neurons, amyloid-β forms oligomers that are thought to disrupt the function of synapses. Immunotherapies and small molecules that inhibit the aggregation and spread of tau are also under development.
If in ammation is shown to contribute to Alzheimer's disease, anti-in ammatory drugs could provide bene ts to those a ected.
